Ayers Duncan, Day Philip J
Centre for Molecular Medicine and Biobanking, University of Malta, Msida MSD 2080, Malta ; Faculty of Medical & Human Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Faculty of Medical & Human Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Mol Biol Int. 2015;2015:698169. doi: 10.1155/2015/698169. Epub 2015 Aug 18.
The exponential development of highly advanced scientific and medical research technologies throughout the past 30 years has arrived to the point where the high number of characterized molecular agents related to pathogenesis cannot be readily integrated or processed by conventional analytical approaches. Indeed, the realization that several moieties are signatures of disease has partly led to the increment of complex diseases being characterized. Scientists and clinicians can now investigate and analyse any individual dysregulations occurring within the genomic, transcriptomic, miRnomic, proteomic, and metabolomic levels thanks to currently available advanced technologies. However, there are drawbacks within this scientific brave new age in that only isolated molecular levels are individually investigated for their influence in affecting any particular health condition. Since their conception in 1992, systems biology/medicine focuses mainly on the perturbations of overall pathway kinetics for the consequent onset and/or deterioration of the investigated condition/s. Systems medicine approaches can therefore be employed for shedding light in multiple research scenarios, ultimately leading to the practical result of uncovering novel dynamic interaction networks that are critical for influencing the course of medical conditions. Consequently, systems medicine also serves to identify clinically important molecular targets for diagnostic and therapeutic measures against such a condition.
在过去30年里,高度先进的科学和医学研究技术呈指数级发展,已达到这样一个程度:大量与发病机制相关的已表征分子因子无法通过传统分析方法轻易整合或处理。事实上,认识到多个部分是疾病的特征,在一定程度上导致了复杂疾病被表征的数量增加。借助当前可用的先进技术,科学家和临床医生现在可以研究和分析在基因组、转录组、微小RNA组、蛋白质组和代谢组水平上发生的任何个体失调情况。然而,在这个科学的全新时代存在一些缺点,即仅单独研究孤立的分子水平对任何特定健康状况的影响。自1992年提出以来,系统生物学/医学主要关注整体通路动力学的扰动对所研究状况的随后发生和/或恶化的影响。因此,系统医学方法可用于在多种研究场景中提供启示,最终导致揭示对影响疾病进程至关重要的新型动态相互作用网络这一实际成果。因此,系统医学还有助于识别针对此类疾病状况的诊断和治疗措施的临床重要分子靶点。